home | publications


1. An assessment of the virtual conversations method for prostate cancer patient education
Harless WG, Zier MA, Duncan RC, Hudak JL, McGarvey MD, McLeod DG.
Urol Nurs. 2007 Dec;27(6):499-506.

2. The design and implementations of a multidisciplinary prostate cancer clinic
Hudak JL, McLeod DG, Brassell SA, Gant DA, Shaar S, Hudak RP, Dean RC, McGarvey MD, Tulin SJ, Dozier R.
Urol Nurs. 2007 Dec;27(6):491-8

3. Editorial Comment on: New Treatment Approaches for Prostate Cancer Based on Peptide Analogues
McLeod DG.
Eur Urol. 2007 Dec 26 [Epub ahead of print]

4. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy
Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G.
Urology. 2007 Dec;70(6):1225-9

5. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells
Miki J, Rhim JS.
Prostate Cancer Prostatic Dis. 2007 Nov 6 [Epub ahead of print]

6. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer
Punglia RS, Cullen J, McLeod DG, Chen Y, D'Amico AV.
Cancer. 2007 Nov 1;110(9):1973-8.

7. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.
Kim KH, Dobi A, Shaheduzzaman S, Gao CL, Masuda K, Li H, Drukier A, Gu Y, Srikantan V, Rhim JS, Srivastava S.
Prostate Cancer Prostatic Dis. 2007;10(1):30-8. Epub 2006 Oct 31.

8. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens
Furusato B, Shaheduzzaman S, Petrovics G, Dobi A, Seifert M, Ravindranath L, Nau ME, Werner T, Vahey M, McLeod DG, Srivastava S, Sesterhenn IA.
Prostate Cancer Prostatic Dis. 2007 Sep 4 [Epub ahead of print]

9. Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin
Li H, Kapur A, Yang JX, Srivastava S, McLeod DG, Paredes-Guzman JF, Daugsch A, Park YK, Rhim JS.
Int J Oncol. 2007 Sep;31(3):601-6.

10. Malignant transformation of human benign prostate epithelial cells by high linear energy transfer alpha-particles
Li H, Gu Y, Miki J, Hukku B, McLeod DG, Hei TK, Rhim JS.
Int J Oncol. 2007 Sep;31(3):537-44.

11. Silencing of Lactotransferrin Expression by Methylation in Prostate Cancer Progression
Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, Petrovics G, Dobi A, Srivastava S.
Cancer Biol Ther. 2007 Jul 20;6(7) [Epub ahead of print]

12. A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer
Richter E, Masuda K, Cook C, Ehrich M, Tadese AY, Li H, Owusu A, Srivastava S, Dobi A.
Epigenetics. 2007 Apr-Jun;2(2):100-9. Epub 2006 Dec 27.

13. Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality
D'Amico AV, McLeod DG, Carroll PR, Cullen J, Chen MH.
Cancer. 2007 Apr 1;109(7):1290-5.

14. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS.
Cancer Res. 2007 Apr 1;67(7):3153-61.

15. Sarcoidosis of the prostate
Furusato B, Koff S, McLeod DG, Sesterhenn IA.
J Clin Pathol. 2007 Mar;60(3):325-6.

16. Androgen receptor and prostate cancer
Richter E, Srivastava S, Dobi A.
Prostate Cancer Prostatic Dis. 2007;10(2):114-8. Epub 2007 Feb 13.